To carry out their activities, Research Teams of the Frédéric Joliot Institute for Life Sciences have developed high-profile technological platforms in many areas : biomedical imaging, structural biology, metabolomics, High-Throughput screening, level 3 microbiological safety laboratory...
Within the Institute, the "Funding Research and Technology Transfer" team is at your disposal to identify the scientists and the skills you need to set up a joint project, to define the terms of a collaboration contract or study.
Whether you are an academic, a SME or an industrialist, our team informs and advices you about the possibilities of consortium assembly, technology transfer, patent licensing or use of our platforms.
The team is also at the disposal of the researchers of the institute to accompany them in achieving their valorization objectives.
Scientific result | Chemistry | Nanomedicine | Cancer | MRI
A SCBM (DMTS) team, in collaboration with researchers at NeuroSpin and I2BC, is describing micellar nanometric vectors targeting tumors that have been imaged by fluorine magnetic resonance imaging (MRI). The observed 19F signal made it possible to precisely delimit the volume of the tumor zone in a mouse model and to quantify the probe accumulated in the target tissue.
Magnetic resonance imaging (MRI) is a non-invasive technique used for the acquisition of anatomical images and functional data. « Conventional » MRI is based on the visualization of protons of the water contained in tissues. However, when the contrast between healthy and pathological tissues is low, it is difficult to obtain usable data. In order to improve image quality, contrast agents such as gadolinium are often administered which, although effective, have limitations (lack of specificity, not directly quantifiable, potential toxicity).In order to obtain a specific and directly quantifiable MRI signal, contrast agents containing, in their structure, atoms directly detectable in MRI, such as fluorine (there is practically no endogenous fluorine in living organisms), are used. Several probes for 19F MRI exist, such as PERFECTA (suPERFluorinatEd ContrasT Agent), unfortunately very poorly soluble in water, which limits its in vivo applications.This is in this context that the SCBM Nanosciences team has developed, in collaboration with a team from UMR BAOBAB (NeuroSpin), micellar nanometric vectors for diagnostic purposes for the targeting of tumors and their visualization by MRI of fluorine 19 in vivo. These amphiphilic vectors incorporate a surface chemistry that allows their passive accumulation in the tumor area and a central reservoir for the encapsulation of a perfluorinated probe (PERFECTA), easily detectable by MRI. The development of an adapted MRI sequence has thus made it possible to visually delimit, with very good sensitivity, the volume of the tumor mass in model mice and to precisely quantify the accumulation of micellar nano-vectors in different organs (Figure).
These results demonstrate the possibility of monitoring in real time the accumulation of micelles in tumor tissues according to an Enhanced Permeability and Retention (EPR) mechanism. This is the first example of the use of such a nano-vector encapsulating the PERFECTA probe.
Contacts : firstname.lastname@example.org; email@example.com; firstname.lastname@example.org
L Jamgotchian, S Vaillant, E Selingue, A Doerflinger, A Belime, M Vandamme, G Pinna, WL Ling, E Gravel, S Mériaux, E Doris. Tumor-targeted superfluorinated micellar probe for sensitive in vivo 19F-MRI. Nanoscale, 2021, 13, 2373-2377 - https://doi.org/10.1039/D0NR08200G
CEA is a French government-funded technological research organisation in four main areas: low-carbon energies, defense and security, information technologies and health technologies. A prominent player in the European Research Area, it is involved in setting up collaborative projects with many partners around the world.